VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
a. VEGFRs may be the biomarker which can predict the effect of bevacizumab in non small cell lung cancer
Non Small Cell Lung Cancer|Brain Metastasis
OTHER: bevacizumab, standard chemotherapy and radiation
PFS, 6 months
OS, 18 months
1. non small cell lung cancer (non squamous carcinoma)
2. ECOG 0-1
3. from 18-75 years old